drugset / Trial / NCT02710448

May Metformin be Used in Renal Failure?

NCT02710448 ↗

NaSingle-groupOpen-labelTreatment

Summary

The study is to treat metformin dose-escalation diabetic subjects of all stages of renal failure (stages 1-5) and compare their rates of erythrocyte metformin (best reflections of a possible accumulation than those of plasma) to the therapeutic range. A number of 12 patients by stage is considered, 60 patients in total.

Timeline

Start
2012-06
Primary completion
2015-06
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Subject Metformin Small molecule 1000 mg Oral
Subject Metformin Small molecule 2000 mg Oral
Subject Metformin Small molecule 3000 mg Oral